Kite Pharma, Inc. Net Income
Kite Pharma, Inc. reported Net Income of -$109.82 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2017-08-08
- Kite Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2017-06-30 was -$109.82M.
- Kite Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2017-03-31 was -$90.40M.
- Kite Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2016-12-31 was -$84.94M.
- Kite Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2016-09-30 was -$73.95M.
- Kite Pharma, Inc. net income (loss) attributable to parent for fiscal 2016 was -$267.07M.
- Kite Pharma, Inc. net income (loss) attributable to parent for fiscal 2015 was -$101.65M.
- Kite Pharma, Inc. net income (loss) attributable to parent for fiscal 2014 was -$42.57M.
- Kite Pharma, Inc. net income (loss) attributable to parent for fiscal 2013 was -$6.37M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$109.82M 10-Q · filed 2017-08-08 | -$200.22M 10-Q · filed 2017-08-08 | -$285.16M derived: sum of 3 quarters · filed 2017-08-08 | -$359.10M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | -$90.40M 10-Q · filed 2017-05-08 | -$175.33M derived: sum of 2 quarters · filed 2017-05-08 | -$249.28M derived: sum of 3 quarters · filed 2017-05-08 | -$313.55M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | -$84.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$158.88M derived: sum of 2 quarters · filed 2017-02-28 | -$223.16M derived: sum of 3 quarters · filed 2017-08-08 | -$267.07M 10-K · filed 2017-02-28 |
| 2016-09-30 | -$73.95M 10-Q · filed 2016-11-09 | -$138.22M derived: sum of 2 quarters · filed 2017-08-08 | -$182.13M 10-Q · filed 2016-11-09 | -$220.37M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | -$64.27M 10-Q · filed 2017-08-08 | -$108.19M 10-Q · filed 2017-08-08 | -$146.42M derived: sum of 3 quarters · filed 2017-08-08 | -$173.86M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$43.92M 10-Q · filed 2017-05-08 | -$82.15M derived: sum of 2 quarters · filed 2017-05-08 | -$109.59M derived: sum of 3 quarters · filed 2017-05-08 | -$130.48M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | -$38.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$65.67M derived: sum of 2 quarters · filed 2017-02-28 | -$86.56M derived: sum of 3 quarters · filed 2017-02-28 | -$101.65M 10-K · filed 2017-02-28 |
| 2015-09-30 | -$27.44M 10-Q · filed 2016-11-09 | -$48.33M derived: sum of 2 quarters · filed 2016-11-09 | -$63.42M 10-Q · filed 2016-11-09 | -$76.44M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$20.89M 10-Q · filed 2016-08-08 | -$35.98M 10-Q · filed 2016-08-08 | -$49.00M derived: sum of 3 quarters · filed 2017-02-28 | -$58.05M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$15.09M 10-Q · filed 2016-05-09 | -$28.11M derived: sum of 2 quarters · filed 2017-02-28 | -$37.16M derived: sum of 3 quarters · filed 2017-02-28 | -$54.52M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$13.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$22.07M derived: sum of 2 quarters · filed 2017-02-28 | -$39.43M derived: sum of 3 quarters · filed 2017-02-28 | -$42.57M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$9.05M 10-Q · filed 2015-11-12 | -$26.41M derived: sum of 2 quarters · filed 2015-11-12 | -$29.55M 10-Q · filed 2015-11-12 | -$31.93M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$17.36M 10-Q · filed 2015-08-10 | -$20.50M 10-Q · filed 2015-08-10 | -$22.88M derived: sum of 3 quarters · filed 2016-02-29 | -$24.37M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$3.14M 10-Q · filed 2015-05-15 | -$5.52M derived: sum of 2 quarters · filed 2016-02-29 | -$7.01M derived: sum of 3 quarters · filed 2016-02-29 | -$8.45M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.87M derived: sum of 2 quarters · filed 2016-02-29 | -$5.30M derived: sum of 3 quarters · filed 2016-02-29 | -$6.37M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$1.49M 10-Q · filed 2014-11-14 | -$2.93M derived: sum of 2 quarters · filed 2014-11-14 | -$3.99M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$1.44M 10-Q · filed 2014-08-14 | -$2.50M 10-Q · filed 2014-08-14 | ||
| 2012-12-31 | -$2.57M 10-K · filed 2015-03-26 |